Back to results
US 8,618,106 B2Granted
Protein kinase inhibitors
AssigneeVertex Pharmaceuticals Incorporated
InventorsJean-Damien Charrier, Steve Durrant
Life of this patent
Estimating the term…
Abstract
In one aspect, the invention provides compounds of Formula I or pharmaceutically acceptable salts thereof. In another aspect, the invention provides methods for treatment of diseases or disorders mediated by a protein kinase, comprising administering a therapeutically effective amount of a compound of this invention.
Claims2
The compound 8-cyclopentyl-7-ethyl-5-methyl-2-(1-phenylethylamino)-7,8-dihydropteridin-6(5H)-one.
Dependencies are inferred from the claim text.